Albert B. DeLeo

9.3k citations

119 papers · 7.7k indexed · 3 hit papers · h-index 44

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways

Papers in

Immunology 77
- Immunotherapy and Immune Responses 61
- Immune Cell Function and Interaction 16
Biotechnology 14
- Cancer Research and Treatments 14

Co-authors: Lloyd J. Old Walter J. Storkus José Mayordomo Laurence Zitvogel Ettore Appella Michael T. Lotze Theresa L. Whiteside Gregory D. Jay
Journals: The Journal of Immunology (13 papers)Proceedings of the National Academy of Sciences (9 papers)The Journal of Experimental Medicine (7 papers)Cancer Immunology Immunotherapy (6 papers)International Journal of Cancer (4 papers)
Partner nations: United States Germany China

In The Last Decade

Albert B. DeLeo

116 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. 1996 · 717 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1996 The Journal of Experimental Medicine
1995 Nature Medicine
1979 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Albert B. DeLeo

Since Specialization

Citations

This map shows the geographic impact of Albert B. DeLeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert B. DeLeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert B. DeLeo more than expected).

Fields of papers citing papers by Albert B. DeLeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert B. DeLeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert B. DeLeo. The network helps show where Albert B. DeLeo may publish in the future.

Co-authors

The 25 scholars most cited alongside Albert B. DeLeo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Albert B. DeLeo Line = papers co-authored together Albert B. DeLeo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram Cell Communication and Signaling ·Ting Sun, Wei Yang, Sneh M. Toprani, Wei Guo, Lile He, Albert B. DeLeo, Soldano Ferrone, Gong Zhang, Enwen Wang, Zunwen Lin, Pan Hu, Xinhui Wang	2020	63
2	Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice Cancer Immunology Research ·Andrea Sobo-Vujanovic, Lazar Vujanović, Albert B. DeLeo, Fernando Concha‐Benavente, Robert L. Ferris, Yan Lin, Nikola L. Vujanović	2016	29
3	Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer Clinical Cancer Research ·Patrick J. Schuler, Malgorzata Harasymczuk, Carmen Visús, Albert B. DeLeo, Sumita Trivedi, Yu L. Lei, Athanassios Argiris, William E. Gooding, Lisa H. Butterfield, Theresa L. Whiteside, Robert L. Ferris	2014	120
4	17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma Gynecologic Oncology ·Marta Szajnik, Mirosław J. Szczepański, Esther Elishaev, Carmen Visús, Diana Lenzner, M. Zabel, Marta Glura, Albert B. DeLeo, Theresa L. Whiteside	2012	25
5	Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells Clinical Cancer Research ·Carmen Visús, Yangyang Wang, Antonio Lozano-León, Robert L. Ferris, Susan A. Silver, Mirosław J. Szczepański, Randall E. Brand, Cristina R. Ferrone, Theresa L. Whiteside, Soldano Ferrone, Albert B. DeLeo, Xinhui Wang	2011	129
6	Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas Cancer Immunology Immunotherapy ·Carmen Visús, Diasuke Ito, Rajiv Dhir, Mirosław J. Szczepański, Yoo Jung Chang, Jean J. Latimer, Stephen G. Grant, Albert B. DeLeo	2011	14
7	CSPG4 in Cancer: Multiple Roles Current Molecular Medicine ·X. Wang, Y. Wang, YU Lianzhen, Koichi Sakakura, Carmen Visús, Joseph H. Schwab, Cristina R. Ferrone, Elvira Favoino, Yoshihiro Koya, Michael Campoli, James B. McCarthy, Albert B. DeLeo, Soldano Ferrone	2010	97
8	Spontaneous apoptosis of tumor‐specific tetramer⁺ CD8⁺ T lymphocytes in the peripheral circulation of patients with head and neck cancer Head & Neck ·Andreas E. Albers, Carsten Schaefer, Carmen Visús, William E. Gooding, Albert B. DeLeo, Theresa L. Whiteside	2009	14
9	Immunological characterization of missense mutations occurring within cytotoxic T cell‐defined p53 epitopes in HLA‐A0201⁺ squamous cell carcinomas of the head and neck International Journal of Cancer* ·Daisuke Ito, Carmen Visús, Thomas K. Hoffmann, Vera Balz, H. Bier, Ettore Appella, Theresa L. Whiteside, Robert L. Ferris, Albert B. DeLeo	2007	27
10	The Wild-Type Sequence (wt) p5325–35 Peptide Induces HLA-DR7 and HLA-DR11-Restricted CD4+ Th Cells Capable of Enhancing the Ex Vivo Expansion and Function of Anti-wt p53264–272 Peptide CD8+ T Cells The Journal of Immunology ·Daisuke Ito, Andreas E. Albers, Yong Zhao, Carmen Visús, Ettore Appella, Theresa L. Whiteside, Albert B. DeLeo	2006	15
11	Increased frequencies of CD8+ T lymphocytes recognizing wild‐type p53‐derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma International Journal of Cancer ·Vito R. Cicinnati, Xia Zhang, Zhengya Yu, S. Ferenčík, Klaus J. Schmitz, Grzegorz Dworacki, Elżbieta Kaczmarek, Karl J. Oldhafer, Andrea Frilling, Hideo Baba, Kurt Werner Schmid, Hans Grosse‐Wilde, Christoph E. Broelsch, Albert B. DeLeo, Guido Gerken, Susanne Beckebaum	2006	22
12	The Ability of Variant Peptides to Reverse the Nonresponsiveness of T Lymphocytes to the Wild-Type Sequence p53264–272 Epitope The Journal of Immunology ·Thomas K. Hoffmann, Douglas J. Loftus, Koji Nakano, Markus Maeurer, Kazuaki Chikamatsu, Ettore Appella, Theresa L. Whiteside, Albert B. DeLeo	2002	51
13	Generation of T Cells Specific for the Wild-Type Sequence p53264–272 Peptide in Cancer Patients: Implications for Immunoselection of Epitope Loss Variants The Journal of Immunology ·Thomas K. Hoffmann, Koji Nakano, Elaine M. Elder, Grzegorz Dworacki, Sydney Finkelstein, Ettore Appella, Theresa L. Whiteside, Albert B. DeLeo	2000	72
14	Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells. PubMed ·Kazuaki Chikamatsu, Koji Nakano, Walter J. Storkus, Ettore Appella, Michael T. Lotze, Theresa L. Whiteside, Albert B. DeLeo	1999	78
15	Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo European Journal of Immunology ·Thomas Tüting, Albert B. DeLeo, Michael T. Lotze, Walter J. Storkus	1997	100
16	The In Vivo Effect of Hepatotrophic Factors Augmenter of Liver Regeneration, Hepatocyte Growth Factor, and Insulin–Like Growth Factor–Ii on Liver Natural Killer Cell Functions Hepatology ·A. Francavilla, Nikola L. Vujanović, Lorenzo Polimeno, Alessandro Azzarone, A. Iacobellis, Albert B. DeLeo, M. Hagiya, Theresa L. Whiteside, Thomas E. Starzl	1997	54
17	Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. The Journal of Experimental Medicine ·Laurence Zitvogel, José Mayordomo, Tjendimin Tjandrawan, Albert B. DeLeo, Martha Clarke, Michael T. Lotze, Walter J. Storkus Hit paper breakdown →	1996	717
18	A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsets. The Journal of Immunology ·Patrick M. Flood, D B Murphy, Marc E. Horowitz, Kenneth LeClair, F R Smith, Elisabeth Stockert, Michael A. Palladino, Albert B. DeLeo	1985	18
19	A cell surface antigen of the mouse related to xenotropic MuLv defined by naturally occurring antibody and monoclonal antibody. Relation to Gix G(rada1), G(aksl2) systems of MuLV-related antigens. The Journal of Experimental Medicine ·Yuuki Obata, Elisabeth Stockert, Albert B. DeLeo, Paul V. O’Donnell, Harry W. Snyder, Lloyd J. Old	1981	17
20	Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma. The Journal of Experimental Medicine ·Dimitrina D. Pravtcheva, Albert B. DeLeo, F.H. Ruddle, Lloyd J. Old	1981	40

About Albert B. DeLeo

Albert B. DeLeo is a scholar working on Immunology, Biotechnology, Oncology, Molecular Biology and Genetics, having authored 119 papers that have together received 7.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (61 papers), Cancer Immunotherapy and Biomarkers (24 papers), Virus-based gene therapy research (21 papers), RNA Interference and Gene Delivery (21 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Immune Cell Function and Interaction (16 papers), vaccines and immunoinformatics approaches (15 papers) and Cancer Research and Treatments (14 papers). The work is most often cited by research in Immunology (4.5k citations), Oncology (3.2k citations), Biotechnology (684 citations), Molecular Biology (3.3k citations) and Genetics (1.0k citations). Albert B. DeLeo has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Lloyd J. Old, Walter J. Storkus, José Mayordomo, Laurence Zitvogel, Ettore Appella, Michael T. Lotze, Theresa L. Whiteside, Gregory D. Jay, Pramod K. Srivastava and L. W. Law. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Cancer Immunology Immunotherapy and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact